Literature DB >> 20207238

Menstrual cycle-related exacerbation of disease.

Joann V Pinkerton1, Christine J Guico-Pabia, Hugh S Taylor.   

Abstract

Exacerbation of common medical and mental health disorders at specific phases of the menstrual cycle is a prevalent phenomenon. Although the precise cause is unclear, studies implicate complex interactions between the immune and neuroendocrine systems. The menstrual cycle also is a trigger for the onset of depressive disorders, including premenstrual dysphoric disorder, a disorder specific to the luteal phase of the menstrual cycle, and depression associated with the transition to menopause. This article discusses common mental health problems exacerbated by the menstrual cycle, with a particular focus on premenstrual dysphoric disorder and perimenopausal depression. Throughout the reproductive lifespan, routine screening and assessment for the presence of common psychiatric disorders are critical for accurate diagnosis and provision of effective treatment. Management options include referral or consultation with a primary care provider or psychiatrist; treatment options for premenstrual dysphoric disorder and perimenopausal depression include pharmacotherapy with antidepressant agents and/or psychotherapy. Hormones may be helpful. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207238      PMCID: PMC3107848          DOI: 10.1016/j.ajog.2009.07.061

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  131 in total

Review 1.  Menstrual cycle effects on common medical conditions.

Authors:  A M Case; R L Reid
Journal:  Compr Ther       Date:  2001

Review 2.  Postmenopausal hormone therapy in clinical perspective.

Authors:  Howard N Hodis; Wendy J Mack
Journal:  Menopause       Date:  2007 Sep-Oct       Impact factor: 2.953

3.  Duloxetine for the treatment of major depressive disorder in women ages 40 to 55 years.

Authors:  Vivien K Burt; Madelaine M Wohlreich; Craig H Mallinckrodt; Michael J Detke; John G Watkin; Donna E Stewart
Journal:  Psychosomatics       Date:  2005 Jul-Aug       Impact factor: 2.386

4.  Variation in symptom severity over the menstrual cycle of schizophrenics.

Authors:  J D Hallonquist; M V Seeman; M Lang; N A Rector
Journal:  Biol Psychiatry       Date:  1993-02-01       Impact factor: 13.382

5.  Antidepressant response and well-being in pre-, peri- and postmenopausal women with major depressive disorder treated with fluoxetine.

Authors:  Paolo Cassano; Claudio N Soares; Cristina Cusin; Alessandra Mascarini; Lee S Cohen; Maurizio Fava
Journal:  Psychother Psychosom       Date:  2005       Impact factor: 17.659

6.  Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

Authors:  Marcia L Stefanick; Garnet L Anderson; Karen L Margolis; Susan L Hendrix; Rebecca J Rodabough; Electra D Paskett; Dorothy S Lane; F Allan Hubbell; Annlouise R Assaf; Gloria E Sarto; Robert S Schenken; Shagufta Yasmeen; Lawrence Lessin; Rowan T Chlebowski
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

Review 7.  The association between premenstrual dysphoric disorder and other mood disorders.

Authors:  K A Yonkers
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

8.  Symptoms in the menopausal transition: hormone and behavioral correlates.

Authors:  Ellen W Freeman; Mary D Sammel; Hui Lin; Clarisa R Gracia; Shiv Kapoor
Journal:  Obstet Gynecol       Date:  2008-01       Impact factor: 7.661

9.  A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study.

Authors:  N E Avis; D Brambilla; S M McKinlay; K Vass
Journal:  Ann Epidemiol       Date:  1994-05       Impact factor: 3.797

10.  Circannual and menstrual rhythm characteristics in manic episodes and body temperature.

Authors:  R B Sothern; G P Slover; R W Morris
Journal:  Biol Psychiatry       Date:  1993-02-01       Impact factor: 13.382

View more
  24 in total

Review 1.  Hormonal contraception and migraine: clinical considerations.

Authors:  Stephanie S Faubion; Petra M Casey; Lynne T Shuster
Journal:  Curr Pain Headache Rep       Date:  2012-10

2.  Effects of social subordination and oestradiol on resting-state amygdala functional connectivity in adult female rhesus monkeys.

Authors:  Katherine M Reding; David S Grayson; Oscar Miranda-Dominguez; Siddarth Ray; Mark E Wilson; Donna Toufexis; Damien A Fair; Mar M Sanchez
Journal:  J Neuroendocrinol       Date:  2020-02-11       Impact factor: 3.627

3.  Depressive symptoms and their relationship with endogenous reproductive hormones and sporadic anovulation in premenopausal women.

Authors:  Ankita Prasad; Enrique F Schisterman; Karen C Schliep; Katherine A Ahrens; Lindsey A Sjaarda; Neil J Perkins; Rebecca Matyas; Jean Wactawski-Wende; Sunni L Mumford
Journal:  Ann Epidemiol       Date:  2014-12       Impact factor: 3.797

4.  Knowledge of and attitudes towards of menstrual disorders adults in north-eastern state of Peninsular Malaysia.

Authors:  Y Nor Asyikin; D Nani; Y Nor Azwany; A Shamsul Kamal; A Imran; I Shaiful Bahari; M Rosediani
Journal:  Malays Fam Physician       Date:  2015-12-31

5.  Patterns and prevalence of medication use across the menstrual cycle among healthy, reproductive aged women.

Authors:  Kristen A Johnson; Lindsey A Sjaarda; Sunni L Mumford; Rebecca A Garbose; Karen C Schliep; Donald Mattison; Neil J Perkins; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-03-08       Impact factor: 2.890

6.  The clinical relevance of self-reported premenstrual worsening of depressive symptoms in the management of depressed outpatients: a STAR*D report.

Authors:  Charlotte L Haley; Sharon C Sung; A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; James F Luther; Susan G Kornstein
Journal:  J Womens Health (Larchmt)       Date:  2013-03       Impact factor: 2.681

7.  Association of premenstrual syndrome and premenstrual dysphoric disorder with bulimia nervosa and binge-eating disorder in a nationally representative epidemiological sample.

Authors:  Carrie J Nobles; Jennifer J Thomas; Sarah E Valentine; Monica W Gerber; Adin S Vaewsorn; Luana Marques
Journal:  Int J Eat Disord       Date:  2016-05-20       Impact factor: 4.861

8.  Characterizing the longitudinal relations between depressive and menstrual symptoms in adolescent girls.

Authors:  Sarah J Beal; Lorah D Dorn; Heidi J Sucharew; Lisa Sontag-Padilla; Stephanie Pabst; Jennifer Hillman
Journal:  Psychosom Med       Date:  2014-09       Impact factor: 4.312

Review 9.  Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice.

Authors:  Franca Fruzzetti; Tiziana Fidecicchi
Journal:  Clin Drug Investig       Date:  2020-12       Impact factor: 2.859

10.  Estrogen attenuates physical and psychological stress-induced cognitive impairments in ovariectomized rats.

Authors:  Mina Khaleghi; Mohammad Amin Rajizadeh; Hamideh Bashiri; Kristi Anne Kohlmeier; Fatemeh Mohammadi; Mohammad Khaksari; Mohammad Shabani
Journal:  Brain Behav       Date:  2021-04-03       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.